ArticleInternational journal of analytical chemistry2026
Validated RP-HPLC-UV Method for Simultaneous Quantification of Aminophenazone, Dipyrine, and Chlorpheniramine Maleate in Pharmaceutical Formulations Considering Dipyrine Decomposition.
Article in International journal of analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Validated RP-HPLC-UV Method for Simultaneous Quantification of Aminophenazone, Dipyrine, and Chlorpheniramine Maleate in Pharmaceutical Formulations Considering Dipyrine Decomposition.International journal of analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aminophenazone, dipyrine, and chlorpheniramine maleate combined drug is used as antipyrine and analgesic. In this study, a rapid, robust, and straightforward high-performance liquid chromatographic (HPLC) technique was developed, optimized, and validated for simultaneous analysis of aminophenazone, dipyrine, and chlorpheniramine maleate taking into account decomposition of dipyrine. On a C18 (4.6 mm × 15 cm; 5 μm) Shim-pack column, aminophenazone, dipyrine, and chlorpheniramine maleate were successfully eluted by using mobile phase, comprising water: methanol: triethylamine: glacial acetic acid (70:28:1:1 v/v/v/v) at flow rate 1.0 mL/min and wavelength of 254 nm. About 5 mg/mL sodium sulfite in diluent and mobile phase was used to prevent the hydrolysis of dipyrine after several investigations. The validation parameters, including specificity, linearity, LOD/LOQ, precision, accuracy, robustness, and solution stability, were verified for performance of the method. In specificity study, there was not any interference with main peak. The constructed calibration curve was found to be linear in the concentration ranges of 0.1-1.0 (aminophenazone), 0.1-1.0 (dipyrine), 0.002-0.020 (chlorpheniramine maleate) mg/mL, respectively. The % recovery at different concentrations was within the (98.0-102.0) %. When the column temperature, the flow rate, wavelength, and mobile phase composition were changed, the absolute difference of the content at different modified conditions were within 2.0 (%RSD) of the original condition. The solution was stable upto 24 h in room temperature (benchtop), autosampler (15°C-25°C), and refrigerator (2-8 degree). This method was successfully employed for the analysis of aminopyrine, metamizole, and chlorpheniramine maleate in marketed products, and the results were satisfactory. The confirmed RP-HPLC-UV method may be a workable analytical approach on a routine analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.